How Much Did Hyperion Biotechnology Raise?
Funding & Key Investors

Hyperion Biotechnology, Inc. has secured $680K in total enterprise-level funding, with its most recent strategic investment amounting to $330K. This significant capital infusion underscores the company's established presence and ongoing development within the biomedical and clinical research sector. The company's funding history, primarily comprising debt financing, indicates a strategic approach to capital management as it continues to serve its diverse client base.

What is Hyperion Biotechnology?

Hyperion Biotechnology
Business ServicesResearch & DevelopmentProject Management

Founded in 1998 and headquartered in San Antonio, Texas, Hyperion Biotechnology, Inc. operates as an 8(m) woman-owned, service-disabled veteran-owned small business. As a certified HUB vendor in the State of Texas, the company specializes in delivering scientific and technology-driven services within the biomedical and clinical research domains. Hyperion Biotechnology is recognized for its comprehensive program support, catering to clients including the U.S. Department of Defense, federal and local government entities, and other organizations. Their service portfolio spans biomedical and clinical research, program management, logistics, medical services, and advisory support, all aimed at enhancing customer programs through streamlined management, process improvement, and efficiency gains.

How much funding has Hyperion Biotechnology raised?

Hyperion Biotechnology has raised a total of $680K across 2 funding rounds:

2020

Debt

$350K

2021

Debt

$330K

Debt (2020): $350K with participation from PPP

Debt (2021): $330K led by PPP

What's next for Hyperion Biotechnology?

The recent major strategic investment positions Hyperion Biotechnology for continued growth and expansion of its service offerings. With a strong foundation in government contracting and a focus on biomedical and clinical research solutions, the company is well-equipped to leverage this capital for enhancing its technological capabilities and broadening its market reach. Future developments are likely to focus on strengthening its role as a key provider of scientific and management services to its government and enterprise clients, potentially exploring new research initiatives or expanding its operational footprint.

See full Hyperion Biotechnology company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Business Services industry

Business ServicesSoftware TestingTelecommunicationsVoIP
Business ServicesProject Management
Business ServicesGraphicsArchitecture, Engineering & DesignConstruction
Business ServicesSoftware Testing

Frequently Asked Questions Regarding Hyperion Biotechnology Financial Insights

What are the most recent funding rounds that Hyperion Biotechnology has completed, and what were the funding rounds?
Hyperion Biotechnology has recently completed 2 funding rounds: Debt on Mar 13, 2021, Debt on Apr 11, 2020.
What is the total amount of funding Hyperion Biotechnology has raised to date?
Hyperion Biotechnology has raised a total of $680K in funding to date.
How many funding rounds has Hyperion Biotechnology completed?
Hyperion Biotechnology has completed 2 funding rounds.
How much funding did Hyperion Biotechnology raise in its most recent funding round?
Hyperion Biotechnology raised $330K in its most recent funding round.
Who are the lead investors in Hyperion Biotechnology's latest funding round?
The lead investor in Hyperion Biotechnology's latest funding round was PPP. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Hyperion Biotechnology's history?
The largest funding round in Hyperion Biotechnology's history was $350K.
See more information about Hyperion Biotechnology